Status:
COMPLETED
NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to assess control of blood sugar, safety, and patient acceptance of insulin aspart compared to insulin lispro, b...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- People with Type I or Type II Diabetes
- 18 Years or Older.
Exclusion
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
513 Patients enrolled
Trial Details
Trial ID
NCT00095446
Start Date
July 1 2004
End Date
March 1 2005
Last Update
January 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Princeton, New Jersey, United States, 08540